Antimicrobial resistance grants
This article was originally published in The Tan Sheet
Executive SummaryCDC announces availability of roughly $600,000 in grant funding for fiscal 2002 for applied research aimed at "prevention and control of the emergence and spread of antimicrobial resistance" in U.S. Program will focus on validation of National Committee for Clinical Laboratory Standards breakpoints for human pathogens of public health importance, according to June 4 Federal Register notice. Research, in form of three separate $200,000 grants, is expected to begin Aug. 30 and continue for up to three years, CDC says. Completed application forms, available on 1CDC Web site, are due July 16...
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.